Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALML3 | P27482 | 6/20 | 0.62 |
| ▸ | MAOA | P21397 | 7/20 | 0.52 |
| ▸ | MAOB | P27338 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6093515 | 0.93 | CALML3 (0.63) | CALML3MAOAMAOBCYP2C19CYP2C9 | |
| SCHEMBL18786530 | 0.93 | CALML3 (0.63) | CALML3MAOAMAOBCYP2C19CYP2C9 | |
| SCHEMBL6092804 | 0.87 | CALML3 (0.59) | CALML3MAOAMAOBCYP2C19CYP2C9 | |
| SCHEMBL6092806 | 0.87 | CALML3 (0.59) | CALML3MAOAMAOBCYP2C19CYP2C9 | |
| SCHEMBL18770280 | 0.86 | CALML3 (0.56) | CALML3MAOAMAOBCYP2C19CYP3A4 | |
| SCHEMBL18790221 | 0.86 | CALML3 (0.56) | CALML3MAOAMAOBCYP2C19CYP3A4 | |
| SCHEMBL1393478 | 0.85 | MAOA (0.65) | CALML3MAOAMAOB | |
| SCHEMBL23060435 | 0.83 | CALML3 (0.59) | CALML3MAOAMAOBCYP2C19CYP2C9 | |
| SCHEMBL18786207 | 0.83 | CALML3 (0.62) | CALML3MAOAMAOBCYP2C19CYP2C9 | |
| SCHEMBL18787358 | 0.83 | CALML3 (0.62) | CALML3MAOAMAOBCYP2C19CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017066964-A1 | OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS | MERCK SHARP & DOHME CORP. (US) | 2017-04-27 | — | — | WO | disclosed |